Two projects underscoring basic/clinical partnerships in translational research have been awarded the two-year, $100,000 grants from the University of Arizona Cancer Center.
Cancer survivors, family, friends, caregivers and the Tucson community are invited to attend Beyond Cancer: Finding Spirit, presented by Community Cancer Connections at the University of Arizona College of Nursing, in partnership with the UA Cancer Center.
Two winners were named Aug. 11 for the Hero Awards at the University of Arizona Cancer Center.
If you haven’t been keeping up with the UA Health Sciences’ Healthy Dose Blog, you might be missing some interesting stories on and by colleagues in the Department of Medicine, related business units and other UAHS colleges.
Here’s a few:
Leaders in the University of Arizona Division of Infectious Diseases wish to express their sadness at the death of Hooshang Nematollahi, MSN, FNP-C, MBA, 62, who passed away Friday, Aug. 25, 2017, after a long battle with thyroid cancer.
His memorial services were held at East Lawn Palms Mortuary in Tucson on Monday, Aug. 28.
By Anna C. Christensen, UA Cancer Center
"5-HT Receptors and Mitochondria Stimulate Recovery from Organ Dysfunction," Rick Schnellman, PhD, Dean, Howard J. Schaeffer Endowed Chair, Professor of Pharmacology and Toxicology, College of Pharmacy and Professor of Medicine and Physiology, University of Arizona College of Medicine - Tucson. Dr. Schnellman is a leading pharmacologist, researcher and drug discovery entrepreneur who joined the UA in August 2016 from the Medical University of South Carolina.
Inflammation affects all of us as we age. Painful joints in arthritis, artery-clogging plaques that can cause heart disease, damaged tissues that can become cancerous—excessive, chronic inflammation underlies each of them. This has led to widespread interest in dietary strategies, lifestyle choices and supplements that may reduce inflammation.
The Valley Fever Center for Excellence (VFCE) at the University of Arizona College of Medicine – Tucson has been awarded a four-year, $4.8 million grant for research to speed development of a vaccine to combat Valley fever, the sometimes deadly respiratory illness caused by Coccidioides spores found in soils of the U.S. Southwest.
Heddwen L.